Examines impact of "authorized generic" pharmaceuticals on scientific innovation. Reviews marketing approval and patent issues for generic drugs, and issues regarding innovation, competition, and public health.
ProQuest U.S. Congressional Research Digital Collection
Note:
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. AVAILABLE ONLINE TO AUTHORIZED PSU USERS.